Self-assembly of amphiphilic phospholipid peptide dendrimer-based nanovectors for effective delivery of siRNA therapeutics in prostate cancer therapy. [electronic resource]
- Journal of controlled release : official journal of the Controlled Release Society 06 2020
- 416-425 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-4995
10.1016/j.jconrel.2020.04.003 doi
Dendrimers Humans Male Peptides Phospholipids Prostatic Neoplasms--drug therapy RNA, Small Interfering